Type 2 diabetes-related health measures during the initial COVID-19 surge at an academic internal medicine practice.
Where this comes from
- Record sourced from PubMed, PMID 38278669.
- Also identified by DOI 10.1016/j.pcd.2024.01.007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The COVID-19 pandemic disrupted chronic disease management in the United States and across the world. This study reports minimal effects of the initial COVID-19 surge on body mass index, blood pressure, cholesterol, and blood glucose control in ambulatory general internal medicine patients with Type 2 diabetes at a single academic center.
Medical subject headings
- Diabetes Mellitus, Type 2
- COVID-19